Pemafibrate
- Generic Name
- Pemafibrate
- Drug Type
- Small Molecule
- Chemical Formula
- C28H30N2O6
- CAS Number
- 848259-27-8
- Unique Ingredient Identifier
- 17VGG92R23
- Background
Pemafibrate is under investigation in clinical trial NCT03350165 (A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)).
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
Phase 3
Completed
- Conditions
- Severe Hypertriglyceridemia
- Interventions
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 551
- Registration Number
- NCT03001817
- Locations
- 🇺🇸
Maryland Cardiovascular Specialist, Baltimore, Maryland, United States
🇺🇸Protenium Clinical Research, LLC - Dallas, Dallas, Texas, United States
🇺🇸Centex Studies, Inc., Houston, Texas, United States
Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers
- First Posted Date
- 2016-10-04
- Last Posted Date
- 2016-12-21
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02922465
Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers
- First Posted Date
- 2016-03-25
- Last Posted Date
- 2016-03-25
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02719431
Drug-Drug Interaction Study in Healthy Adult Volunteers
- First Posted Date
- 2014-10-27
- Last Posted Date
- 2016-02-01
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02275962
- Locations
- 🇺🇸
PPD, Austin, Texas, United States
Drug-Drug Interaction Study in Healthy Adult Volunteers
- First Posted Date
- 2014-10-27
- Last Posted Date
- 2014-10-27
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02275988
- Locations
- 🇺🇸
PPD, Austin, Texas, United States
Drug-Drug Interaction Study in Healthy Adult Volunteers
- First Posted Date
- 2014-10-27
- Last Posted Date
- 2014-10-27
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02276001
- Locations
- 🇺🇸
PPD, Austin, Texas, United States
Drug-Drug Interaction Study in Healthy Adult Volunteers
- First Posted Date
- 2014-10-27
- Last Posted Date
- 2014-10-27
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02275975
- Locations
- 🇺🇸
PPD, Austin, Texas, United States
Drug-Drug Interaction Study in Health Adult Volunteers
- First Posted Date
- 2014-10-24
- Last Posted Date
- 2014-10-24
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT02273986
- Locations
- 🇺🇸
PPD, Austin, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath